Histological transformation in lung adenocarcinoma: Insights of mechanisms and therapeutic windows

Area of Science:

• Oncology
• Cancer Biology
• Translational Medicine

Background:

• Histological transformation of lung adenocarcinoma (ADC) into other cancer types like small cell lung carcinoma (SCLC) is a known resistance mechanism to targeted therapies.
• This transformation often leads to a poor prognosis and limited survival for patients, with a lack of effective treatment options.
• Understanding the underlying mechanisms of this histological shift is critical for developing novel therapeutic strategies.

Purpose of the Study:

• To provide a comprehensive overview of the molecular features and signaling pathways involved in histological transformation of ADC.
• To summarize potential therapeutic approaches targeting transformed lung cancers based on current findings.

Main Methods:

• Literature review of studies investigating histological transformation in lung adenocarcinoma.
• Analysis of molecular alterations and signaling pathways in transformed lung tumors.
• Synthesis of proposed mechanisms including intratumoral heterogeneity, cancer stem cells, and suppressor gene alterations.

Main Results:

• Histological transformation to SCLC, LCNEC, SCC, and PSC is a recognized resistance mechanism in ADC targeted therapy.
• Proposed mechanisms include intratumoral heterogeneity, cancer stem cells, and alterations in suppressor genes.
• Current treatment options for transformed lung cancers are limited, highlighting the need for further research.

Conclusions:

• Histological transformation in lung adenocarcinoma represents a significant challenge in cancer treatment, necessitating a deeper understanding of its molecular basis.
• Further research into the mechanisms driving transformation and the development of targeted therapies is crucial for improving patient outcomes.
• This review consolidates current knowledge on molecular features and potential therapeutic strategies for transformed lung cancers.